Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

Ketamine: taking aim at depression

Since the turn of the millennium, researchers have been investigating ketamine as a potential treatment for major depression. Today, with the largest trial to date underway and several ketamine-like drugs under development, we are moving closer to understanding its true potential. Abi Millar investigates.

Go Top